nach oben

Reactions Weekly

Erschienen in:

01.04.2018 | Case report

Methylprednisolone

Myopathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

In a prospective study of 21 patients, one patient [age and sex not stated] was described, who developed myopathy during treatment with methylprednisolone [route not stated]. The patient, who had sarcoidosis, started receiving treatment with methylprednisolone, which was decreased to 16 mg/day. Thereafter, it was adjusted at a maintenance dose of 8 mg/day. However, at the end of the treatment, the patient developed steroid-induced myopathy [time to reaction onset and outcome not stated]. …

Ozdemir L, et al. A prospective review of the results of patients treated and followed up for a diagnosis of sarcoidosis. Turkish Thoracic Journal 19: 1-6, No. 1, 2018. Available from: URL: http://doi.org/10.5152/TurkThoracJ.2017.17028 - TurkeyCrossRefPubMed

Titel: Methylprednisolone
Myopathy: case report
Publikationsdatum: 01.04.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-45175-5

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Methylprednisolone

Myopathy: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Methylprednisolone/prednisolone acetate/triamcinolone

Bevacizumab

Ramucirumab

Canagliflozin

Benzatropine/diphenhydramine/haloperidol

Rituximab